Ferumoxytol, a superparamagnetic iron oxide nanoparticle, is commonly used as an intravenous treatment for anemia, but has been recently employed as a blood-pool contrast agent for MRI. Here we evaluated Ferumoxytol as a tool to improve the neuronal specificity of fMRI using it for both improved vascular segmentation and for CBV-weighted functional contrast. We employed multi-echo gradient recalled echo (ME-GRE) acquisitions with functional imaging pre and post injection, performed vascular extraction/segmentation, and report apparent quantitative CBV changes surrounding vessels as a function of echo-time. This work demonstrates the possibility of high-resolution CBV mapping, gray- and white-matter angiography, and cortical depth-dependent analyses with this contrast agent.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords